Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone.
Peball M, Krismer F, Knaus HG, Djamshidian A, Werkmann M, Carbone F, Ellmerer P, Heim B, Marini K, Valent D, Goebel G, Ulmer H, Stockner H, Wenning GK, Stolz R, Krejcy K, Poewe W, Seppi K; Collaborators of the Parkinson's Disease Working Group Innsbruck. Peball M, et al. Ann Neurol. 2020 Oct;88(4):712-722. doi: 10.1002/ana.25864. Epub 2020 Aug 31. Ann Neurol. 2020. PMID: 32757413 Free PMC article. Clinical Trial.
Cannabinoids for Treatment of Dystonia in Huntington's Disease.
Saft C, von Hein SM, Lücke T, Thiels C, Peball M, Djamshidian A, Heim B, Seppi K. Saft C, et al. Among authors: peball m. J Huntingtons Dis. 2018;7(2):167-173. doi: 10.3233/JHD-170283. J Huntingtons Dis. 2018. PMID: 29562549
Gait and postural disorders in parkinsonism: a clinical approach.
Raccagni C, Nonnekes J, Bloem BR, Peball M, Boehme C, Seppi K, Wenning GK. Raccagni C, et al. Among authors: peball m. J Neurol. 2020 Nov;267(11):3169-3176. doi: 10.1007/s00415-019-09382-1. Epub 2019 May 22. J Neurol. 2020. PMID: 31119450 Free PMC article. Review.
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study).
Peball M, Werkmann M, Ellmerer P, Stolz R, Valent D, Knaus HG, Ulmer H, Djamshidian A, Poewe W, Seppi K. Peball M, et al. J Neural Transm (Vienna). 2019 Aug;126(8):1061-1072. doi: 10.1007/s00702-019-02021-z. Epub 2019 May 25. J Neural Transm (Vienna). 2019. PMID: 31129719 Free PMC article. Clinical Trial.
Augmentation in restless legs syndrome: an eye tracking study on emotion processing.
Ellmerer P, Heim B, Stefani A, Peball M, Werkmann M, Holzknecht E, Bergmann M, Brandauer E, Sojer M, Zamarian L, Delazer M, Seppi K, Högl B, Poewe W, Djamshidian A. Ellmerer P, et al. Among authors: peball m. Ann Clin Transl Neurol. 2020 Sep;7(9):1620-1627. doi: 10.1002/acn3.51144. Epub 2020 Aug 12. Ann Clin Transl Neurol. 2020. PMID: 32786065 Free PMC article.
Has Deep Brain Stimulation Changed the Very Long-Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study.
Mahlknecht P, Peball M, Mair K, Werkmann M, Nocker M, Wolf E, Eisner W, Bajaj S, Quirbach S, Peralta C, Eschlböck S, Wenning GK, Willeit P, Seppi K, Poewe W. Mahlknecht P, et al. Among authors: peball m. Mov Disord Clin Pract. 2020 Sep 21;7(7):782-787. doi: 10.1002/mdc3.13039. eCollection 2020 Oct. Mov Disord Clin Pract. 2020. PMID: 33033735 Free PMC article.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
38 results